Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Long before modern pharmaceutical labs began to rely on complex synthetic polymers, cellulose caught the attention of chemists with its natural abundance and reliability. Early twentieth-century experiments led to various cellulose derivatives, and ethyl cellulose quickly stood out for its chemical flexibility. Researchers saw right away that swapping out hydrophilic hydroxyl groups for ethyl groups made cellulose dissolve more readily in organic solvents. Companies invested in methods to control substitution and purity, setting off a race that still shapes industrial cellulose chemistry. The introduction of regulatory standards in the twentieth century — and subsequent alignment with international pharmacopeial standards (BP, EP, USP) — guided manufacturers toward ever-stricter quality benchmarks.
Manufacturers create ethyl cellulose for the pharmaceutical trade by fine-tuning both the source material and the reaction process. Each bag carries a specific “low viscosity” rating, which tells users right away about chain length and flow properties. The BP, EP, and USP labels assure compliance with major pharmacopeial monographs, providing a common language for pharmacists worldwide. Sitting between plant-derived integrity and synthetic consistency, this product fits especially well with the needs of drug formulators who demand known properties and reliable lot-to-lot behavior.
Visual inspection reveals ethyl cellulose as an odorless, white to light-tan powder. Handling it, you’ll notice the fine granularity and lack of grit, a direct result of high-purity processing. Chemically, its backbone remains cellulose, but repeating hydroxyls give way to ethyl ether groups, producing a substance both hydrophobic and soluble in many organic solvents. Viscosity measurements — often expressed using a 5% solution in toluene/ethanol or similar — provide a practical handle on polymer weight and branching. On a molecular level, average substitution almost always lands between 2 and 2.6 ethyl groups per glucose unit, striking a balance between flexibility and robustness.
Labels for ethyl cellulose in the pharma world read like a map for safe and effective use. Besides grade and viscosity, you’ll often see the degree of substitution, moisture content (typically under 5%), and trace analyses for heavy metals or residual solvents. Careful attention is given to particle size distribution, since even small variations affect blending and tablet characteristics. International shipment demands harmonized labeling, including batch numbers, storage recommendations, and expiry dates to guarantee regulatory alignment. Pharmacopeial markings assure practitioners and regulators that the material meets strict identity, purity, and performance criteria.
Getting ethyl cellulose ready for pharma grade use involves several carefully orchestrated steps. Starting with purified cellulose — often from high-quality wood pulp or cotton linters — the process moves to activation with sodium hydroxide and subsequent ethylation, where ethyl chloride gas or liquid reacts under basic conditions. This substitution doesn't just hop on willy-nilly: process engineers control temperature, reactant ratios, and reaction time to reach the desired substation level. The raw polymer undergoes a series of washes to strip out salts, unreacted chemicals, and water-soluble byproducts, followed by careful drying under reduced pressure. The resulting flakes or granules are milled to a fine powder, sieved, and checked for tight quality benchmarks before packaging.
On its own, ethyl cellulose doesn't hydrolyze easily and keeps its backbone intact in most environments. Water can't crack it open, and acids or bases barely dent its resistance under ambient conditions. Researchers sometimes take things further: crosslinking or blending with compatible polymers, or introducing additives that shift solubility, film formation, or flexibility. These tweaks rely on a sound understanding of the cellulose backbone’s limits and the ethyl groups’ reliability. There’s always some curiosity about how the molecule might handle a new formulation demand — but for most pharmaceutical applications, the basic product covers the ground needed.
Ethyl cellulose turns up under several brand names and designations. Chemists might call it “cellulose ethyl ether” or note it as EC in documentation, but manufacturers often stamp containers with proprietary trade names. Pharmaceutical and regulatory circles stick to the generic naming described in compendia — “Ethyl Cellulose BP,” “Ethyl Cellulose EP,” or “Ethyl Cellulose USP” — connecting each lot to clearly documented standards and test procedures. It helps everyone, from purchasing agents to lab techs, keep things straight and avoid any confusion with other cellulose ethers like hydroxypropyl methylcellulose.
Long experience shows ethyl cellulose carries a low risk in routine lab and industrial handling. Dust control matters, since inhalation can trigger mild respiratory irritation, and gloves help keep powder from drying out your skin. Material safety data sheets spell out good house practices — control airborne dust, store in a cool, dry spot, and keep away from open flames. No one wants to see drift into injection lines or tablet coating pans: so, air filtration and close control of batch records stand as central pillars of safety culture. Plant engineers keep an eye on static electricity build-up, which can ignite organic powder under some conditions. Each handling step links directly to good manufacturing practice, and any reputable operation integrates internal audits to spot drift from safe storage, cleaning, or weighing.
Ethyl cellulose holds a unique spot in modern drug manufacturing. As a film former and binder, it shows up everywhere from sustained-release coatings to taste-masking for bitter drugs. Its water-insolubility helps time-release designs — the classic slow-percolating tablet that keeps a steady trickle of active drug in the bloodstream. Oral suspensions, microcapsule wall materials, and even some topical gels link back to the smooth texture and low reactivity that ethyl cellulose brings to the table. Over-the-counter and prescription medicines both draw on its versatility, but the material routinely finds life in food additives and personal care as well, thanks to long-standing regulatory acceptance and broad documentation.
Pharmaceutical scientists constantly look for new ways to harness ethyl cellulose in advanced delivery forms. Teams in academia and industry use model drugs and tablets to probe tablet disintegration, swelling, and release kinetics. People study how particle size affects coating thickness and film continuity, or how compatible plasticizers and excipients change tablet strength. Every few years, a breakthrough paper proposes a smarter tablet design, often supported by studies that dive deep using NMR, electron microscopy, or dynamic mechanical testing. Academic research also digs into hybrid systems — blending ethyl cellulose with other polymers to handle poorly water-soluble drugs. If there’s a grail here, it’s probably the dream of a universal matrix for foolproof, custom-tailored drug release. For all the innovation, most breakthroughs must pass the reality check of regulatory review and real-world scale-up.
Safety profiles for ethyl cellulose consistently read as benign. Decades of studies support the position that, at normal usage levels, the material poses little risk for acute or chronic toxicity. It doesn’t metabolize in the gut, and most animal studies report that it passes through without accumulation. Mutagenicity and carcinogenicity studies — both in vitro and in animal models — come back negative; regulators around the world accept its use in both pharmaceuticals and food. Occasional research looks at high-dose or chronic exposure, but the margin of safety remains generous. That track record gives scientists and regulators confidence, though vigilance never truly ends; changing manufacturing practices, trace contaminants, or new formulations must each clear thorough evaluation before any broad claim on safety applies.
Looking forward, ethyl cellulose is poised to retain a strong position in drug formulation. Researchers and manufacturers both see potential in fine-tuning the polymer — maybe with better plasticizers, smarter particle engineering, or more responsive delivery systems. Advanced 3D printing of medicines, a hot topic these days, already leans on tried-and-tested materials like ethyl cellulose to build intricate release profiles. Supply chain integrity and regulatory harmonization stay at the top of the industry’s checklist. As sustainability and recycling gain ground, companies revisit how cellulose feedstock gets sourced and processed. Experienced chemists know that even venerable materials like this don’t stand still; real progress often happens at the intersection of careful craft, steady research, and listening to the evolving needs of patients.
Pharmaceutical companies often look for ingredients that can do more than just one job. Ethyl cellulose—especially in its low viscosity, high-purity forms—comes up time and again. My first experience with it came in the lab, where we tried to solve a common problem: how to keep a tablet from falling apart in the bottle, but let it break down reliably in the body. Ethyl cellulose helped bridge that gap.
Low viscosity ethyl cellulose attracts attention for its ability to control how medicines dissolve after swallowing. I remember blends where only slight adjustments to ethyl cellulose level changed the drug’s release from immediate to slow. This makes it crucial for extended-release and sustained-release tablets. It acts almost like a tailored jacket for medicine—the coating doesn’t dissolve in stomach acid, so the drug gets released slowly along the digestive path.
Making tablets isn’t as simple as mixing powder and compressing it. Sometimes the powder doesn’t stick or breaks easily. Ethyl cellulose often works as a binder, making sure each tablet holds its shape and survives shipping. Pharma-grade quality matters here, especially since any impurity can introduce risk. Regulatory bodies like the FDA stress ingredient purity for a reason; one tiny deviation can cause a recall and backtrack trust.
Some active pharmaceutical ingredients taste bitter or have a strong odor. Spending a day around uncoated pills in production will convince anyone—taste-masking matters. Ethyl cellulose builds a protective layer, so patients swallowing these medicines don’t grimace. This protective coating works in syrup and chewable forms too. Less taste, more patient compliance.
Ethyl cellulose also finds jobs outside pharmaceuticals, though pharma grades follow tighter rules. It appears in food, cosmetics, and paints, each use requiring different particle sizes and viscosity. But in medicine, purity and predictability carry the most weight. My work with a nutraceuticals company drove home the point: cheap grades don’t cut it, especially when products make health claims.
Many manufacturers worry about process consistency. Using the pharma-grade version cuts down on lot-to-lot variability, which is a real headache. One batch could process fine, the next could clog up machines or ruin a whole run of tablets. Investing in better mixing equipment and tighter process controls helps, but starting with higher-quality excipients gives manufacturers a head start.
Drug resistance to coating breakdown can pose another challenge. Some patients need drugs to break down faster or slower, depending on their condition. Formulators often partner closely with suppliers and do real-world taste tests, dissolution studies, and patient feedback loops to fine-tune recipes. Regulatory audits sometimes make this painstaking, but skipping steps isn’t an option when patient safety is on the line.
Patients and parents rarely ask what makes up their pills or capsules, yet tiny changes in excipients can cause big headaches. Without careful ingredient choice and top-tier manufacturing practices, tablets may dissolve too quickly or barely at all. As chronic diseases climb and aging populations require precision dosing, the value of ingredients like low viscosity ethyl cellulose grows. Choosing better quality isn’t just a technical detail—it’s a decision that directly shapes public health.
Most people wouldn’t know ethyl cellulose if it showed up on their kitchen shelf, but step into a pharmaceutical lab, and this white, free-flowing powder holds a lot of significance. Ethyl cellulose (EC), especially its low viscosity, pharma grade, shapes some of the world’s most trusted tablets and capsules. As someone who spent years in a pharmaceutical production environment, I have seen how much the consistent performance of this material matters for drug development and patient safety.
Ethyl cellulose is all about cleanliness and clarity. Pharma grade means the product reaches a level of purity that regulators and health professionals can trust. This grade almost always contains more than 99% ethyl cellulose by dry weight. Moisture content lands well below 5%. Over years on the production floor, I’ve watched batches tested for chloride and heavy metals—levels stay below 0.02% for chloride and just a handful of parts per million for metals.
Microbial contamination receives even tighter scrutiny. Manufacturers keep total aerobic counts under 100 cfu/g, while yeast and mold typically drop to undetectable levels. For medicines, anything less than clean could end up posing big risks down the road.
The viscosity standard deserves its own mention. Low viscosity usually means measured values fall between 5 and 15 centipoise (cP) in a 5% to 10% solution (usually tested in a 20°C ethanol-water mixture). In tablet manufacture, this translates to a binder that handles smoothly in mixing and allows even film-coating. Delivering precise viscosity ensures repeatable drug release profiles, batch after batch.
Other important specs cover things like ethoxy content—often between 48% and 49.5%. This percentage helps control solubility and compatibility with other pharmaceutical ingredients. The powder sits white and odorless, free from foreign matter, which is checked by simple visual inspection and UV spectrometry.
Using and producing this pharma grade excipient isn’t just about ticking boxes. The U.S. Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Indian Pharmacopoeia all set out detailed monographs. Each batch needs certificates of analysis proving alignment with these standards. Audits and supplier visits happen regularly—I’ve personally worked through surprise inspections, and the paper trail never sits idle for long.
Regulators expect traceability for each raw material batch, test results archived for several years, and samples retained that could be tested long after medicines reach patients. This traceability really protects both brands and people who depend on these drugs.
At times, keeping that powder dry is a real battle, especially in humid climates. If moisture creeps above the spec limit, it ruins tablet processing, destroys film quality, and—worst of all—increases risk of bacterial spoilage. Smart packaging, silica gel inserts, and climate-controlled logistics keep this excipient within its safe range.
On the testing side, outsourcing labs once led to delays and batch holds, so many pharma firms have brought rapid, in-house techniques such as Fourier-transform infrared (FTIR) and nuclear magnetic resonance (NMR) for higher precision, saving both time and money. Sharing test data across global supply partners, and keeping lines of communication open with suppliers, turned out to be just as important as the paperwork.
Pharma lives or dies on the back of trust—both in the science and in the quality behind every ingredient. Ethyl cellulose, though nearly invisible to the public, remains one of those pieces that prove how small choices make big differences. The people measuring viscosity and purity aren’t just keeping up appearances—they’re protecting lives.
Pharmacies and drug manufacturers work with many types of ingredients, but ethyl cellulose stands out for its toughness and flexibility. I’ve watched small and large labs try different binders and coatings, and it’s clear ethyl cellulose (especially in its low viscosity grade) has carved out a perfect niche. This material helps control how tablets release their medicine. It can keep bitter tastes locked away or give a capsule long-lasting release so people don’t need to take a pill every few hours. That’s not just convenient—it keeps drug levels in the blood steadier, which can mean far better health outcomes.
Regulations in the pharmaceutical world are strict for a reason. No one wants to risk unstable or inconsistent drugs. Ethyl cellulose with BP (British Pharmacopoeia), EP (European Pharmacopoeia), and USP (United States Pharmacopeia) marks meets the standards for purity, safety, and performance set by authorities in different regions. I’ve seen formulators lean toward these grades because they know what they’re getting—a pure material without surprise contaminants, tested for properties like residue and heavy metals. There’s trust in the label. When I check sourcing paperwork, suppliers that provide documentation to prove these grades give teams peace of mind.
Low viscosity in ethyl cellulose changes the game for certain processes. It pours and mixes more easily, especially when making fine coatings or using the material as a binder. Tablets require coatings that aren’t clumpy, and for that, viscosity needs to sit at a level that lets machines handle the ingredient predictably. I remember a technical hiccup in one plant with thicker grades—the coating just wouldn’t spread properly, giving inconsistent finish across batches. Once the switch to a lower viscosity grade happened, the machines could coat every pill in the same way—no more rough patches or uneven coloring.
Patients depend on drugs to remain stable through their shelf life. Ethyl cellulose doesn’t degrade easily; heat and most chemicals don’t break it down. That matters in hot cramped pharmacies or shipping containers. The BP, EP, and USP standards take this into account by setting criteria for identity, loss on drying, and chemical residue. These reduce the risk of nasty surprises that could hurt people who rely on daily medication. My time on quality review teams has shown how a single shipment failing purity tests can disrupt months of planning. Knowing ethyl cellulose comes vetted under strict guidelines really makes audits smoother and protects patient safety.
Working with any pharmaceutical excipient, including ethyl cellulose, still means paying attention to finer details. Not every drug plays well with it. Sometimes a formulation won’t work if a slow-release coating blocks absorption, or if allergies become an issue. Manufacturers should always run stability and compatibility tests, tracking how medicines behave months after production. For the very rare cases where ethyl cellulose doesn’t fit the bill, alternatives like hydroxypropyl methylcellulose or polyvinylpyrrolidone might offer a path forward.
Right now, low viscosity ethyl cellulose with BP, EP, and USP grades offers a reliable, well-tolerated option for coatings, sustained release, and masking taste in pharmaceuticals. With the unrelenting pressure to innovate and shorten time to market, industry veterans often stick with it to avoid regulatory rework and patient risk. Continued effort to check purity and traceability will keep it an industry favorite, and as technology develops, its uses might continue to grow.
Ethyl cellulose steps into plenty of industries, especially pharmaceuticals, food, and specialty coatings. Picking the right way to store and handle this powder isn’t just about following textbook procedures—it’s about keeping your workspace safe, your material stable, and your workflow efficient. Over the years, I’ve seen plenty of folks underestimate these basics, only to realize how quickly a straightforward mishap can grow out of proportion.
You can pour a lot of energy into sourcing a high-quality batch of ethyl cellulose, but if a facility pulls in moisture or the storage room heats up over summer, the powder starts clumping and becomes a pain to work with. Store it in a space that feels dry and shaded, away from fluctuating temperatures. I recommend a room kept below 30°C, with humidity levels in check. Even if ethyl cellulose isn’t as moisture-hungry as some other excipients, humidity draws out the worst in it—stickiness and uneven dispersal.
Most people stick to the manufacturer’s container. That’s wise because it usually seals tight. Once you start opening and closing the bag, exposure piles up. Reseal straight away or transfer to a drum or airtight jar—don’t leave scoops sitting for “later.” I once watched a whole batch absorb so much water overnight that it took hours sifting and sieving to make it usable for coating trials again.
It’s easy to overlook powder management. Open a bag too quickly, and the air fills with fine particles. Besides making a mess, ethyl cellulose powder poses real respiratory hazards. Dust can irritate lungs, especially in workshops without good ventilation. I’ve always stuck by a simple rule: gloves, masks, safety goggles, and, if possible, a fume hood or a local exhaust system. From my own experience, people are less likely to skip these steps when they’re widely available and within arm’s reach. It’s about making smart choices routine, not a chore.
Ethyl cellulose plays well with most materials, but it doesn’t tolerate strong acids, alkalis, or oxidizers. You risk changing its structure or igniting an unwanted reaction. Take inventory of nearby chemicals—don’t just assume the cleaning team will pick up on unsafe storage. In my early days, I saw a careless shelf arrangement lead to contamination in a batch, ruining days of effort. Have clear labeling on containers, and don’t double up your workspace.
Someone might scoff at the idea of planning for spills, but the powder can scatter and settle into corners, where it attracts pests or, worse, becomes a fire hazard. Clean up using a vacuum with a HEPA filter or damp cloth, never sweeping, to avoid raising more dust. For disposal, local regulations often list ethyl cellulose as non-hazardous, though it’s smart to segregate the waste. Never pitch it into drains or open areas. A disciplined approach today means fewer surprises tomorrow.
Ethyl cellulose brings value where stability and safety count. Careful handling—dry rooms, sealed storage, protective gear—prevents headaches down the road. From what I’ve learned, habits build trust, both in your materials and your team. Taking shortcuts to save ten minutes rarely pays off. With the right habits, you gain both peace of mind and a product that lives up to its promise.
Ethyl cellulose shows up everywhere from pharmaceuticals to food coatings. Beyond keeping tablets together or holding up barriers in controlled-release drugs, it’s found in a lot of products you’ve probably used. Its versatility relies on how much you add and what exactly you want it to do. In my days behind the pharmacy counter, I saw firsthand how a small shift in concentration could turn a decent tablet into a disappointment that customers returned.
For oral solid dosage forms, the typical concentration ranges between 2% to 25%. Fast-release tablets, meant to dissolve quickly, stay at the low end of that spectrum. Slow-release or sustained-release tablets push toward higher levels, even up to 25%. Once you go past 25%, tablets might become too hard or slow to dissolve, creating headaches for both patients and professionals. Ethyl cellulose creates that invisible membrane, resisting water just enough so medicines don’t disperse too quickly. Studies highlight how a 10% to 20% concentration achieves a sweet spot in most controlled-release systems.
In food, ethyl cellulose works as a stabilizer and thickener. The food industry generally sticks to 0.1% to 5%, far below what pharmaceuticals use. Go higher and the texture gets weird—think of grease on popcorn or a coating on candy that won’t melt in your mouth.
Paints and coatings rely on ethyl cellulose for body and adhesion. Here, concentrations land around 2% to 6%. Push past 6%, and viscosity climbs so high the product becomes clumpy or too thick to handle. A seasoned paint chemist told me, “It only takes a couple of grams too much before the batch is ruined.”
Regulators like the FDA and EMA pay close attention to ingredients like ethyl cellulose. Their limits aren’t just bureaucratic hurdles—they’re built from years of real-world testing and patient feedback. Formulators stick to recommended ranges not just for safety but because better results follow. If the amount gets too high, drugs risk failing dissolution tests. Too little, and the intended effect might not happen at all.
Data from the United States Pharmacopeia (USP) and studies in the Journal of Pharmaceutical Sciences echo this: tightly controlled concentration drives predictable performance. Even something as simple as humidity during manufacturing can nudge the ideal range slightly.
Pharmaceutical companies rely on trial batches and dissolution profiles to nail down the ideal ratio. Food companies test for taste, texture, and safety. Industrial mixers look for stability and spread. The starting point? Published recommendations, but tweaks based on pilot batches and quality control checks.
Every step counts. If you’re working with ethyl cellulose, treat the recommended dosage as a strong guide, not gospel. Build in test runs at both ends of the published range. Record everything: not just measurements, but temperature changes and timing. Draw on practical experience—yours and the community’s—so small changes don’t catch you off-guard.
Real-world experience shows precise dosing keeps products safe, stable, and user-friendly. Leaning on thorough documentation and regulatory guidance, companies avoid costly recalls. Ethyl cellulose’s success in formulations comes down to measured use, constant testing, and a genuine respect for what a few percentage points up or down can do. Without that attention, even the most reliable ingredient can go sideways.
| Names | |
| Preferred IUPAC name | O-ethylcellulose |
| Other names |
Ethyl Cellulose Ethylcellulose Ethyl ether of cellulose Cellulose ethyl ether EC |
| Pronunciation | /ˈiːθɪl sɛlˈjuːloʊs/ |
| Identifiers | |
| CAS Number | 9004-57-3 |
| Beilstein Reference | 85846 |
| ChEBI | CHEBI:53215 |
| ChEMBL | CHEMBL1208270 |
| ChemSpider | 33364 |
| DrugBank | DB14029 |
| ECHA InfoCard | 20c8d53d-4290-4f7d-8dfb-498f6c9c8536 |
| EC Number | 9004-57-3 |
| Gmelin Reference | 65153 |
| KEGG | C01837 |
| MeSH | D002477 |
| PubChem CID | 107314 |
| RTECS number | KI8750000 |
| UNII | 3NXW29V3WO |
| UN number | UN1219 |
| CompTox Dashboard (EPA) | DTXSID1020496 |
| Properties | |
| Chemical formula | C6H7O2(OC2H5)x(OH)3−x |
| Appearance | White or almost white powder |
| Odor | Odorless |
| Density | 0.4 – 0.5 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 1.3 |
| Vapor pressure | Negligible |
| Basicity (pKb) | 13.86 |
| Refractive index (nD) | 1.47 |
| Viscosity | 5 to 15 cps |
| Dipole moment | 2.2 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 679.5 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -7560 kJ/mol |
| Pharmacology | |
| ATC code | No ATC code |
| Hazards | |
| GHS labelling | GHS labelling of Ethyl Cellulose (Low Viscosity) BP EP USP Pharma Grade: `"Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008 (CLP/GHS)"` |
| Pictograms | GHS02,GHS07 |
| Signal word | No signal word |
| Hazard statements | Hazard statements: Not a hazardous substance or mixture according to the Globally Harmonized System (GHS). |
| Precautionary statements | P261, P305+P351+P338 |
| NFPA 704 (fire diamond) | **2-2-1** |
| Flash point | > 330°C |
| Autoignition temperature | 335 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): > 5,000 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): >5,000 mg/kg |
| NIOSH | KI7475000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Ethyl Cellulose: Not established. |
| REL (Recommended) | REL (Recommended): 2.5 mg/m³ |
| Related compounds | |
| Related compounds |
Cellulose Methyl Cellulose Hydroxypropyl Cellulose Hydroxypropyl Methylcellulose Carboxymethyl Cellulose Nitrocellulose |
Chengguan District, Lanzhou, Gansu, China
